Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

Clinical trial NCT06568328 · RECRUITING

Trial details

NCT number: NCT06568328
Sponsor: Fujian Medical University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Graft vs Host Disease

Start date: 2024-09-01
Primary completion: 2026-01-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.